Parirenyatwa Hospital
Harare, 00263, Zimbabwe
NCT Number: NCT02833441
Youth with evidence of virologic failure defined as an HIV VL>400 copies/mL on two consecutive occasions at least 1 month apart will be eligible for enrollment. Youth will be randomized to a community based peer counseling support group or clinic based standard of care, with viral load, and drug monitoring evaluations at 3 month intervals to determine the efficacy of the intervention in improving adherence and virologic suppression.
Looking for future studies?
Notify Me10 year–24 year
All sexes
Interventional
Not applicable
Harare, 00263, Zimbabwe
Title The Peer Support Intervention - supporting HIV positive adolescents in Zimbabwe to improve HIV care continuum outcomes
Short Title The Peer Support Intervention
Study Design Prospective randomized study
Study Duration 2 years
Study Population 250 Youth (ages 10-24 years) with virologic failure
Study Outcomes Primary Outcomes
Secondary Outcomes
Description of Intervention Youth with evidence of virologic failure defined as an HIV VL>400 copies/mL on two consecutive occasions at least 1 month apart will be eligible for enrollment. Youth will be randomized to a community based peer counseling support group or clinic based standard of care, with viral load, and drug monitoring evaluations at 3 month intervals to determine the efficacy of the intervention in improving adherence and virologic suppression.
Study Sites Parirenyatwa Hospital Family Care Centre
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years
Virologic suppression
Time frame: 2 years
drug resistance mutations
Time frame: 2 years
psychological distress
Time frame: 2 years
psychological distress
Time frame: 2 years
(viral load), DBS and hair (tenofovir concentrations).
Time frame: 2 years
detection of drug resistance
University of Zimbabwe
Other
Acronym: PESU
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06125509
HIV
Tallahassee, Florida, United States
View Trial DetailsNCT07225894
Behavior, HIV
Kisumu, Kisumu County, Kenya
View Trial DetailsNCT02447159
Behavior, Blood-Borne Infections
Eket, Akwa Ibom State, Nigeria
View Trial DetailsNCT03734393
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Birmingham, Alabama, United States
View Trial Details